Review Registration - Organization
Return to Mental Health and Addictions in Active Registrations on: 2022-12-31

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 907737
Submitted by lobbyist on: January 24, 2019 03:17:37 PM
Accepted by Registrar on: January 24, 2019 03:36:04 PM

Designated Filer Information

Harrington, Kevin  
588 Roslyn Blvd  
North Vancouver, BC, V7G 1P3
604-929-9155
Canada  

Organization Information

AbbVie Corporation  
AbbVie is biopharmaceutical company that formerly was a part of Abbott Laboratories (prior to Jan 1, 2013). AbbVie has a research, commercial infrastructure capabilities rooted in a 125-year legacy. We develop advanced therapies that address complex and serious diseases.
588 Roslyn Blvd  
North Vancouver, BC, V7G 1P3
604-929-9155
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

January 24, 2019  
July 24, 2019  

Organization's In-House Lobbyists

 



Name: Harrington, Kevin
 
January 24, 2019  
Inactivation Date: July 31, 2019

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder for purpose of lobbying

Development, establishment, amendment or termination of any program, policy or decision

Gain and maintain reimbursement of AbbVie products as per provincial and national HTA reviews and defined criteria by Pharmacare , BC Cancer Agency and Regional Health Authorities. Also discuss health policy and the role and outcomes of pharmaceuticals in providing BC healthcare funding sustainability and improved patient outcomes. On behalf of Innovative Medicines Canada provide demonstrate the value of medicines to patients and the BC health care system .

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health January 24, 2019
MLA Glumac, Rick Port Moody-Coquitlam January 24, 2019
MLA Isaacs, Joan Coquitlam-Burke Mountain January 24, 2019
MLA Letnick, Norm Kelowna-Lake Country January 24, 2019

Science and Technology

Development, establishment, amendment or termination of any program, policy or decision

Creating an environment for enhanced BC life sciences eco-system as it relates to investment and research. Job creation and growth of BC's knowledge-based economy. Facilitating "value demonstrating initiatives" partnerships in BC.

Target Contacts

Target Type Name Title or Constituency Date Added
Staff of MLA McNish, James Surrey-Whalley April 4, 2019
Staff of MLA Szabo, Maria Surrey-Whalley April 4, 2019
Minister Glumac, Rick Parliamentary Secretary for Technology January 24, 2019
Minister Mark, Melanie Minister of Advanced Education, Skills and Training January 24, 2019
Minister Ralston, Bruce Minister of Jobs, Trade and Technology January 24, 2019

Return to Mental Health and Addictions in Active Registrations on: 2022-12-31